The Cu(II) reductase RclA protects Escherichia coli against the combination of hypochlorous acid and intracellular copper
Rhea M. Derke, Alexander J. Barron, Caitlin E. Billiot, Ivis F. Chaple, Suzanne E. Lapi, Nichole A. Broderick, Michael J. Gray
Inflammatory bowel diseases (IBDs) are a growing health concern. Enterobacteria, including Escherichia coli, bloom to high levels in the gut during inflammation and strongly contribute to the pathology of IBDs. To survive in the inflamed gut, E. coli must tolerate high levels of antimicrobial compounds produced by the immune system, including toxic metals like copper and reactive chlorine oxidants like hypochlorous acid (HOCl). In this work, we show that the widely-conserved bacterial HOCl resistance enzyme RclA catalyzes the reduction of copper (II) to copper (I), and specifically protects E. coli against the combination of HOCl and intracellular copper, probably by preventing Cu(III) accumulation. E. coli lacking RclA were highly sensitive to HOCl and were defective in colonizing an animal host. Our results indicate unexpected complexity in the interactions between antimicrobial toxins produced by innate immune cells and suggest an important and previously unsuspected role for copper redox reactions during inflammation.
Circular dichroism, Thermal stability, Secondary structure, Biochemistry